LOGIN
ID
PW
MemberShip
2022-10-04 06:11
All News
Policy
Company
Product
Opinion
InterView
검색
Dailypharm Live Search
Close
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
Input Time : 2019-12-23
[Download file]
go back
OPINION
Reimbursement of Zerbaxa
Reporter's view |
Eo, Yun-Ho
Bio-Administrative Orders of the USA
Reporter's view |
Kim, Jin-Gu
Reform of the innovative system
Reporter's view |
Lee, Jeong-Hwan
INTERVIEW
“Will rise independently as Organon in the industry”
So Eun Kim, Managing Director of Organon Korea
"Leclaza’s mOS data of 38.9 months is remarkable"
Tremfya to bring generation shift in the IL inhibitor market
Tremfya Marketing Team at Janssen Korea
“Roche reborn through customer-centric reorganization”
[Interview] Nic Horridge, General Manager of Roche Korea
Otrivin package made user-friendly for pharmacist & patient
Yewon Moon, Brand Manager, GSK Consumer Healthcare
Data
Roche 2018 Annualreport
Roche 2018 Annualreport
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
MOST READ
1
Il-Yang “has not exaggerated COVID-19 trial results
2
Pharmaceuticals trying to dominate Saxenda obesity market
3
Post-marketing surveillance of breast cancer drug Kadcyla
4
The price of Zerbaxa is listed at 60,098 won
5
[Reporter's view] Reimbursement of Zerbaxa
